Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Cyclosporine Therapy in Female Renal Transplant Patients

Critical Side Effects

  • Nephrotoxicity is the most significant safety concern with cyclosporine therapy, occurring through increased vascular resistance, reduced renal blood flow, and decreased creatinine clearance, according to Kidney International 2, 3, 5, 6, 7
  • Acute nephrotoxicity is reversible with dose reduction or discontinuation, but chronic use can cause irreversible structural changes including interstitial fibrosis, arteriolar hyalinosis, and tubular atrophy, as reported by Kidney International and British Journal of Dermatology 2, 3, 5, 6, 8

Common Cosmetic Side Effects

  • Hirsutism occurs in approximately 21% of transplant patients and is the most common cutaneous side effect, particularly significant for women with darker hair, according to the Journal of the American Academy of Dermatology and British Journal of Dermatology 1, 8, 10
  • Gingival hyperplasia occurs in 4-9% of transplant patients, as reported by the Journal of the American Academy of Dermatology 1

Other Important Side Effects

  • Hypertension occurs in approximately 50% of renal transplant patients on cyclosporine, according to Praxis Medical Insights 9
  • Early morning resting blood pressure is a more sensitive indicator of early nephrotoxicity than elevated creatinine, as stated by Praxis Medical Insights 9
  • Calcium channel blockers are the preferred antihypertensive agents as they are nephroprotective and do not interact with cyclosporine metabolism, according to Praxis Medical Insights 9
  • Nausea and vomiting occur in up to 10% of patients, and diarrhea occurs in up to 8% of patients, as reported by Praxis Medical Insights 4
  • Hyperkalemia can occur, particularly with potassium-sparing diuretics, according to the Journal of the American Academy of Dermatology and Praxis Medical Insights 1, 4

Special Considerations for Female Patients

  • Women should be counseled about pregnancy risks before starting therapy, as stated by Praxis Medical Insights 11, 4
  • Cyclosporine passes into breast milk and contains ethanol that will be absorbed by the nursing infant, according to the Journal of the American Academy of Dermatology and Praxis Medical Insights 1, 11, 4

Critical Drug Interactions to Avoid

  • Nephrotoxic drugs potentiate renal dysfunction, as reported by the Journal of the American Academy of Dermatology 1
  • Grapefruit and grapefruit juice increase cyclosporine blood levels and must be avoided, according to the Journal of the American Academy of Dermatology 1
  • Drugs metabolized by CYP3A4 may have altered levels, as stated by the Journal of the American Academy of Dermatology and Praxis Medical Insights 1, 4

REFERENCES

9

Cyclosporine-Induced Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

10

Cyclosporine Side Effects and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

11

Cyclosporine Safety During Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025